Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CLASSIFY: Insulin Lispro Mix25 vs Mix50 as Starter Insulin in Type 2 Diabetes
jRCT1080222124Phase 4Recruiting
- Sponsor
- Eli Lilly and Company
- Start
- Jun 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial in type 2 diabetes mellitus (T2DM) comparing Insulin Lispro Mix25 twice daily with Insulin Lispro Mix50 twice daily (2 arms). Started Jun 2013; status: recruiting.
02
Drugs
insulin lispro mix25insulin lispro mix 50/50
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on jRCT1080222124.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080222124.